» Articles » PMID: 10330038

Extracellular Matrix Deposition by Primary Human Lung Fibroblasts in Response to TGF-beta1 and TGF-beta3

Overview
Journal Am J Physiol
Specialty Physiology
Date 1999 May 18
PMID 10330038
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Increased collagen and extracellular matrix (ECM) deposition within the lung is a characteristic feature of lung fibrosis. Transforming growth factor (TGF)-beta isoforms play a pivotal role in the production of collagen and ECM. In this study, we investigated the effects of TGF-beta1 and TGF-beta3 on the main processes controlling ECM deposition using primary human lung fibroblasts. We analyzed 1) collagen metabolism by [3H]proline incorporation, 2) matrix metalloproteinase (MMP) expression by substrate gel zymography, and 3) tissue inhibitor of metalloproteinases (TIMP) expression by Western blot analysis. TGF-beta1 and TGF-beta3 increased the percentage of secreted collagens in supernatants of primary fibroblasts from 8.0 +/- 1.2 (control) to 23.6 +/- 4.6 and 22.3 +/- 1.3%, respectively. The collagen percentage in deposited ECM was increased from 5.8 +/- 0.3 (control) to 9.0 +/- 0.5 and 8.8 +/- 0.5% by TGF-beta1 and TGF-beta3, respectively. Secretion of MMP-1 (interstitial collagenase) by fibroblasts was reduced by both TGF-beta isoforms, whereas secretion of MMP-2 (gelatinase A) was unaffected by either of the two isoforms. Both TGF-beta isoforms increased TIMP-1 protein expression, whereas TIMP-2 protein was decreased. We thus conclude that TGF-beta1 and TGF-beta3 are equally potent in increasing ECM deposition. Their fibrotic effect in lung fibroblasts results from 1) an increase in the secretion and deposition of total ECM and collagens, 2) a decrease in MMP-1 secretion, and 3) an increase of TIMP-1 expression.

Citing Articles

Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives.

Crowley L, Stockley R, Thickett D, Dosanjh D, Scott A, Parekh D Eur Respir Rev. 2024; 33(174).

PMID: 39603661 PMC: 11600124. DOI: 10.1183/16000617.0139-2024.


Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective.

Danielpour D Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675493 PMC: 11054419. DOI: 10.3390/ph17040533.


LRG1 Promotes ECM Integrity by Activating the TGF-β Signaling Pathway in Fibroblasts.

Park H, Song M, Choi Y, Lee D, Chung J, Lee S Int J Mol Sci. 2023; 24(15).

PMID: 37569820 PMC: 10418909. DOI: 10.3390/ijms241512445.


Decoding the molecular landscape of keloids: new insights from single-cell transcriptomics.

Xia Y, Wang Y, Shan M, Hao Y, Liang Z Burns Trauma. 2023; 11:tkad017.

PMID: 37293384 PMC: 10244213. DOI: 10.1093/burnst/tkad017.


The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis.

Stephenson K, Porte J, Kelly A, Wallace W, Huntington C, Overed-Sayer C Respir Res. 2023; 24(1):89.

PMID: 36949463 PMC: 10035257. DOI: 10.1186/s12931-023-02334-4.